RENAISSANCE TECHNOLOGIES LLC

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in ACRV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,350,776

+$296,545 QoQ

Shares Held

758,863

+0.1% QoQ

Ownership

1.77%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 46 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. ACRV ranks #162 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,350,776	758,863	+0.1%	Shares	Sole	2026-08-13
2026-03-31	$1,054,231	758,440	+19.6%	Shares	Sole	2026-05-14
2025-12-31	$1,528,347	634,169	+1.7%	Shares	Sole	2026-02-12
2025-09-30	$1,128,354	623,400	+22.4%	Shares	Sole	2025-11-13
2025-06-30	$606,061	509,295	+877.5%	Shares	Sole	2025-08-13
2025-03-31	$105,763	52,100	+5.5%	Shares	Sole	2025-05-14
2024-12-31	$297,388	49,400	+7.6%	Shares	Sole	2025-02-13
2024-09-30	$321,300	45,900	-15.8%	Shares	Sole	2024-11-13
2024-06-30	$316,100	54,500	-46.9%	Shares	Sole	2024-08-09
2024-03-31	$733,590	102,600	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.